Ghetie VF - Search Results

1

Immunology. Considering therapeutic antibodies.

Vitetta ES, Ghetie VF. Vitetta ES, et al. Among authors: ghetie vf. Science. 2006 Jul 21;313(5785):308-9. doi: 10.1126/science.1130482. Science. 2006. PMID: 16857927 No abstract available.

2

HIV-infected cells are killed by rCD4-ricin A chain.

Till MA, Ghetie V, Gregory T, Patzer EJ, Porter JP, Uhr JW, Capon DJ, Vitetta ES. Till MA, et al. Science. 1988 Nov 25;242(4882):1166-8. doi: 10.1126/science.2847316. Science. 1988. PMID: 2847316

3

Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.

Pincus SH, Song K, Maresh GA, Hamer DH, Dimitrov DS, Chen W, Zhang MY, Ghetie VF, Chan-Hui PY, Robinson JE, Vitetta ES. Pincus SH, et al. Among authors: ghetie vf. J Virol. 2017 Jan 18;91(3):e01955-16. doi: 10.1128/JVI.01955-16. Print 2017 Feb 1. J Virol. 2017. PMID: 27852851 Free PMC article.

4

An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons.

Saavedra-Lozano J, McCoig C, Xu J, Cao Y, Keiser P, Ghetie V, Siliciano RF, Siliciano JD, Picker LJ, Ramilo O, Vitetta ES. Saavedra-Lozano J, et al. J Infect Dis. 2002 Feb 1;185(3):306-14. doi: 10.1086/338565. Epub 2002 Jan 8. J Infect Dis. 2002. PMID: 11807712

5

Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice.

Smallshaw JE, Ghetie V, Rizo J, Fulmer JR, Trahan LL, Ghetie MA, Vitetta ES. Smallshaw JE, et al. Nat Biotechnol. 2003 Apr;21(4):387-91. doi: 10.1038/nbt800. Epub 2003 Mar 10. Nat Biotechnol. 2003. PMID: 12627168

6

The evaluation of recombinant, chimeric, tetravalent antihuman CD22 antibodies.

Meng R, Smallshaw JE, Pop LM, Yen M, Liu X, Le L, Ghetie MA, Vitetta ES, Ghetie V. Meng R, et al. Clin Cancer Res. 2004 Feb 15;10(4):1274-81. doi: 10.1158/1078-0432.ccr-1154-03. Clin Cancer Res. 2004. PMID: 14977825

7

The generation of immunotoxins using chimeric anti-CD22 antibodies containing mutations which alter their serum half-life.

Pop LM, Liu X, Ghetie V, Vitetta ES. Pop LM, et al. Int Immunopharmacol. 2005 Jul;5(7-8):1279-90. doi: 10.1016/j.intimp.2005.03.013. Epub 2005 Apr 26. Int Immunopharmacol. 2005. PMID: 15914332

8

Generation and characterization of a novel tetravalent anti-CD22 antibody with improved antitumor activity and pharmacokinetics.

Liu XY, Pop LM, Roopenian DC, Ghetie V, Vitetta ES, Smallshaw JE. Liu XY, et al. Int Immunopharmacol. 2006 May;6(5):791-9. doi: 10.1016/j.intimp.2005.11.022. Epub 2005 Dec 22. Int Immunopharmacol. 2006. PMID: 16546710

9

A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia.

Schindler J, Gajavelli S, Ravandi F, Shen Y, Parekh S, Braunchweig I, Barta S, Ghetie V, Vitetta E, Verma A. Schindler J, et al. Br J Haematol. 2011 Aug;154(4):471-6. doi: 10.1111/j.1365-2141.2011.08762.x. Epub 2011 Jul 7. Br J Haematol. 2011. PMID: 21732928 Free PMC article. Clinical Trial.

10

Immunotoxins for the treatment of B-cell lymphomas.

Ghetie MA, Ghetie V, Vitetta ES. Ghetie MA, et al. Mol Med. 1997 Jul;3(7):420-7. Mol Med. 1997. PMID: 9260154 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters